Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10639354 Treatment of hyperinsulinemic hypoglycemia with exendin (9-39)

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
May 23, 2016
0
Date of Patent
May 5, 2020
0
Patent Application Number
15576647
0
Patent Citations
‌
US Patent 10188702 Methods and compositions for treating hypoglycemic disorders
Patent Citations Received
‌
US Patent 11617782 Treatment of post-bariatric hypoglycemia with exendin (9-39)
0
‌
US Patent 11020484 Buffered formulations of exendin (9-39)
‌
US Patent 12102663 Treatment of post-bariatric hypoglycemia with exendin (9-39)
0
‌
US Patent 11622995 Treatment of post-bariatric hypoglycemia with GLP-1 antagonists
0
‌
US Patent 10993992 Treatment of post-bariatric hypoglycemia with GLP-1 antagonists
‌
US Patent 10993991 Treatment of post-bariatric hypoglycemia with exendin (9-39)
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10639354
0
Patent Primary Examiner
‌
Julie Ha
0

Find more entities like US Patent 10639354 Treatment of hyperinsulinemic hypoglycemia with exendin (9-39)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.